A better buy-in window may exist right now for Gilead Sciences Inc. (GILD)

Gilead Sciences Inc. (NASDAQ: GILD) stock jumped 0.60% on Wednesday to $79.05 against a previous-day closing price of $78.58. With 5.86 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.34 million shares. During the session, the Drug Manufacturers – General company that operates in wider Healthcare sector, reached to the highest price of $79.26 whereas the lowest price it dropped to was $78.14. The 52-week range on GILD shows that it touched its highest point at $89.74 and its lowest point at $57.17 during that stretch. It currently has a 1-year price target of $91.58. With its current market cap of 97.81 billion, GILD has annualized dividend of $3.00 while the current yield stands at 3.80%. Beta for the stock currently stands at 0.41.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GILD was up-trending over the past week, with a rise of 0.30%, but this was down by -7.64% over a month. Three-month performance dropped to -4.23% while six-month performance fell -6.28%. The stock gained 24.18% in the past year, while it has lost -7.92% so far this year. A look at the trailing 12-month EPS for GILD yields 4.42 with Next year EPS estimates of 7.18. For the next quarter, that number is 1.71. This implies an EPS growth rate of -26.20% for this year and 5.91% for next year. EPS is expected to grow by 2.25% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -13.90%.

Float and Shares Shorts:

At present, 1.25 billion GILD shares are outstanding with a float of 1.23 billion shares on hand for trading. On Apr 27, 2023, short shares totaled 19.28 million, which was 1.55% higher than short shares on Mar 30, 2023. In addition to Mr. Daniel P. O’Day as the firm’s Chairman & CEO, Mr. Andrew D. Dickinson serves as its Exec. VP & CFO.

Institutional Ownership:

Through their ownership of 85.97% of GILD’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 53.34% of GILD, in contrast to 32.24% held by mutual funds. Shares owned by individuals account for 1.32%. As the largest shareholder in GILD with 8.62% of the stake, The Vanguard Group, Inc. holds 107,532,951 shares worth 107,532,951. A second-largest stockholder of GILD, BlackRock Fund Advisors, holds 81,698,515 shares, controlling over 6.55% of the firm’s shares. Capital Research & Management Co is the third largest shareholder in GILD, holding 76,500,240 shares or 6.13% stake. With a 3.11% stake in GILD, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 38,764,925 shares are owned by the mutual fund manager. The American Funds Income Fund of Ame, which owns about 2.71% of GILD stock, is the second-largest Mutual Fund holder. It holds 33,735,334 shares valued at 2.77 billion. Vanguard 500 Index Fund holds 2.35% of the stake in GILD, owning 29,269,426 shares worth 2.41 billion.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, GILD reported revenue of $6.26B and operating income of $2.36B. The EBITDA in the recently reported quarter was $2.08B and diluted EPS was $0.91.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GILD since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GILD analysts setting a high price target of $115.00 and a low target of $77.00, the average target price over the next 12 months is $91.50. Based on these targets, GILD could surge 45.48% to reach the target high and fall by -2.59% to reach the target low. Reaching the average price target will result in a growth of 15.75% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Dividends & Yield:

In terms of dividends, GILD has a current ratio of $3.0, which is $3.0 over the trailing 12-months, while a dividend of $2.62 is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and GILD currently yields $3.72. In the past year, GILD’s dividend yield has been $3.72, but when looking at the stock over the past five years, its yield has been $3.85. Accordingly, GILD has a current buyback yield of $1.15. This was $1.15 for the TTM, and it was $1.61 for the past five years.

Summary of Insider Activity:

Insiders traded GILD stock several times over the past three months with 18 Buys and 10 Sells. In these transactions, 97,184 shares were bought while 67,299 shares were sold. The number of buy transactions has increased to 56 while that of sell transactions has risen to 40 over the past year. The total number of shares bought during that period was 593,964 while 218,827 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *